USPTO serial 99063855
PCI PHARMA SERVICES
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- SAXTON, EVELYN H
- Law office
- TMO LAW OFFICE 112
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PCI PHARMA SERVICES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard E. Peirce
Richard E. Peirce Eckert Seamans Cherin & Mellott, LLC50 S. 16th Street, 22nd FloorPhiladelphia, PA 19102-2516United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 039 | Packaging and labeling of pharmaceutical materials used in clinical trials for others; biologics packaging for others | ACTIVE | — |
| 040 | Custom manufacture of pharmaceuticals; Custom manufacture of biopharmaceuticals; Biomanufacture of pharmaceuticals to order and specification of others | ACTIVE | — |
| 042 | Pharmaceutical drug development services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 23, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 23, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 23, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 15, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 17, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 17, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 17, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Nov 13, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Aug 17, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 17, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 17, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 13, 2025 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Jun 13, 2025 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Mar 3, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 3, 2025 | NWAP | NEW APPLICATION ENTERED | — |